Cargando…

Alterations in peripheral levels of cytokines and associated inflammatory markers in acute and chronic stages of schizophrenia spectrum disorders: a systematic review and network meta-analysis

INTRODUCTION: It has been previously identified that levels of peripheral inflammatory proteins, such as cytokines, are altered in people with schizophrenia spectrum disorders (SSD). OBJECTIVES: As there is considerable inconsistency in the literature with respect to how inflammatory profiles differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halstead, S., Siskind, D., Amft, M., Wagner, E., Yakimov, V., Liu, Z., Walder, K., Warren, N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434679/ http://dx.doi.org/10.1192/j.eurpsy.2023.1042

Ejemplares similares

Pro-inflammatory cytokine alterations in unaffected first-degree relatives of schizophrenia patients
por: Kurtulmus, A.
Publicado: (2021)

S178. ALTERED GYRIFICATION IN THE SCHIZOPHRENIA SPECTRUM
por: Sasabayashi, Daiki, et al.
Publicado: (2018)

Inflammatory cytokines dysfunction in autism spectrum disorder
por: Ben Othman, A., et al.
Publicado: (2021)

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2018)

Features of the inflammatory response at the long-term stages of juvenile schizophrenia
por: Zozulya, S. A., et al.
Publicado: (2023)

Inflammatory markers and indicators of systemic endotoxemia in patients with treatment-resistant schizophrenia
por: Zozulya, S. A., et al.
Publicado: (2023)

PM344. Association between peripheral cytokine levels and cognitive abilities in children with autism spectrum disorder
por: Sasayama, Daimei, et al.
Publicado: (2016)

Advances in Staging of schizophrenia. Development of an empirical staging model for schizophrenia.
por: Garcia-Portilla, P.
Publicado: (2023)

Clozapine levels and therapeutic response: using individual patient meta-analysis data for a ROC Curve analysis
por: Northwood, K., et al.
Publicado: (2023)

F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE
por: Pikalov, Andrei, et al.
Publicado: (2018)

Subpopulation composition of monocytes and inflammation markers in schizophrenia
por: Zozulya, S. A., et al.
Publicado: (2023)

Alterations in brain myelination at early-stage schizophrenia detected by macromolecular proton fraction MRI
por: Krupina, E., et al.
Publicado: (2023)

Depression and quality of life in schizophrenia-spectrum
por: Smaoui, N., et al.
Publicado: (2021)

41.1 WHAT DO META-ANALYSES TELL US ABOUT CLOZAPINE’S EFFICACY AND EFFECTIVENESS FOR TREATMENT REFRACTORY SCHIZOPHRENIA?
por: Siskind, Dan, et al.
Publicado: (2018)

PT584. Peripheral inflammatory markers in Alzheimer’s disease and mild cognitive impairment
por: Kim, Yo Sup, et al.
Publicado: (2016)

Language and turn-taking in schizophrenia spectrum disorders
por: Dusi, L., et al.
Publicado: (2022)

A pilot study of the associations between inflammatory markers and the presence of „deficit syndrome” in schizophrenia patients
por: Michalczyk, A., et al.
Publicado: (2022)

T160. TREATMENT OF CLOZAPINE-ASSOCIATED OBESITY AND DIABETES WITH EXENATIDE (CODEX) IN ADULTS WITH SCHIZOPHRENIA: A RANDOMISED CONTROLLED TRIAL
por: Siskind, Dan, et al.
Publicado: (2018)

Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode Schizophrenia
por: Baek, Seon-Hwa, et al.
Publicado: (2022)

28.4 FLEXIBLE BODY BOUNDARY AND ALTERED MAPPING OF THE BODILY SELF IN THE SCHIZOPHRENIA SPECTRUM: CAUSES, PROCESSES AND POTENTIAL INTERVENTION
por: Park, Sohee, et al.
Publicado: (2018)

O1.2 PERIPHERAL INFLAMMATORY MARKERS ARE PREDICTIVE OF CLINICAL CHARACTERISTICS AND OUTCOME IN PSYCHOSIS
por: Blackman, Graham, et al.
Publicado: (2018)

Cytokine Alterations in Schizophrenia: An Updated Review
por: Momtazmanesh, Sara, et al.
Publicado: (2019)

Marker of schizophrenia with enduring negative symptoms
por: Dmitrieva, E., et al.
Publicado: (2022)

F128. THE AGE OF ONSET OF SCHIZOPHRENIA SPECTRUM DISORDERS
por: Miettunen, Jouko, et al.
Publicado: (2018)

Decision making and implicit suicidality in schizophrenia spectrum disorders
por: Vorontsova, O., et al.
Publicado: (2021)

Schizophrenia may be considered as a member of the spectrum of PBAFopathies
por: Abdelmoula, B., et al.
Publicado: (2023)

Long-term prediction of multidimensional social inclusion among patients with schizophrenia spectrum disorder
por: Hao, J., et al.
Publicado: (2023)

S194. INVESTIGATING PERIPHERAL MICRORNA-MRNA INTERACTIONS IN SCHIZOPHRENIA
por: Geaghan, Michael, et al.
Publicado: (2018)

Prodromal stage and clinical features of late-onset schizophrenia and schizophrenia-like psychosis
por: Pochueva, V., et al.
Publicado: (2023)

Correlation between alterations in cognitive function and mean severity of psychotic symptoms in patients diagnosed with schizophrenia spectrum disorders and its clinical application
por: Malliaris, P., et al.
Publicado: (2021)

T210. PSYCHOSOCIAL CORRELATES OF INTERPERSONAL PLEASURE IN SCHIZOPHRENIA-SPECTRUM PATIENTS
por: Gooding, Diane, et al.
Publicado: (2018)

Childhood trauma in schizophrenia spectrum disorders and intensity of psychotic symptoms
por: Alvarez, M.-J., et al.
Publicado: (2021)

DIMENSIONAL DIAGNOSIS IN SCHIZOPHRENIA SPECTRUM DISORDERS: A CASE REPORT
por: Cusenza, A. S., et al.
Publicado: (2023)

T140. RESTING STATE NETWORKS ALTERATION IN SCHIZOPHRENIA
por: Mingoia, Gianluca, et al.
Publicado: (2018)

PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder
por: Yoo, Nam Hee, et al.
Publicado: (2016)

Comparative study of treatment adherence, treatment-related attitudes, and background factors in schizophrenia spectrum and bipolar patients
por: Janicsák, H., et al.
Publicado: (2022)

Oppel – Kundt illusion manifestation among people with schizophrenia spectrum disorders
por: Pečkutė, A., et al.
Publicado: (2022)

An empirical staging model for schizophrenia using machine learning
por: Clara, M.-C., et al.
Publicado: (2023)

Infections, inflammatory markers and schizophrenia
por: Dickerson, F., et al.
Publicado: (2014)

INFECTIONS, INFLAMMATORY MARKERS AND SCHIZOPHRENIA
por: Dickerson, Faith, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_snkg6fb59h3f40a301dsp01ct6